Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic

Ítems similars

• Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
  per: Benenson, Irina, et al.
  Publicat: (2020)
• More Good News on Statins and COVID-19
  per: Katsiki, Niki, et al.
  Publicat: (2021)
• Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
  per: Jarcho, John A., et al.
  Publicat: (2020)
• Renin–angiotensin–aldosterone system inhibitors and COVID-19
  per: Quinn, Kieran L., et al.
  Publicat: (2020)
• COVID-19 and inhibitors of the renin–angiotensin–aldosterone system
  per: Hussain, Musaddique, et al.
  Publicat: (2020)